0001203311-20-000132.txt : 20201123
0001203311-20-000132.hdr.sgml : 20201123
20201123201112
ACCESSION NUMBER: 0001203311-20-000132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201119
FILED AS OF DATE: 20201123
DATE AS OF CHANGE: 20201123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRYSKA DAVID W
CENTRAL INDEX KEY: 0001202335
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 201339558
MAIL ADDRESS:
STREET 1: 749 N MARY AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-11-19
0
0001060736
Seagen Inc.
SGEN
0001202335
GRYSKA DAVID W
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
0
0
0
Common Stock
2020-11-19
4
M
0
7129
19.02
A
51977
D
Common Stock
2020-11-19
4
S
0
7129
174.2
D
44848
D
Common Stock
2020-11-19
4
M
0
7871
19.02
A
52719
D
Common Stock
2020-11-19
4
S
0
7871
173.25
D
44848
D
Non-Qualified Stock Option (right to buy)
19.02
2020-11-19
4
M
0
7129
0.0
D
2021-05-20
Common Stock
7129
7871
D
Non-Qualified Stock Option (right to buy)
19.02
2020-11-19
4
M
0
7871
0.0
D
2021-05-20
Common Stock
7871
0
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Reflects sales of common stock executed in multiple transactions at prices ranging from $173.75 to $174.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $172.75 to $173.74 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Options were fully vested on 5/20/12.
By: /s/ Jean Liu For: David W. Gryska
2020-11-23